Section of Pulmonary, Critical Care, and Respiratory Services, Washington Hospital Center, Washington, DC.
Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC.
Chest. 2012 Aug;142(2):385-393. doi: 10.1378/chest.11-1764.
The detection of pulmonary nodules (PNs) is likely to increase, especially with the release of the National Lung Screen Trials. When tissue diagnosis is desired, transthoracic needle aspiration (TTNA) is recommended. Several guided-bronchoscopy technologies have been developed to improve the yield of transbronchial biopsy for PN diagnosis: electromagnetic navigation bronchoscopy (ENB), virtual bronchoscopy (VB), radial endobronchial ultrasound (R-EBUS), ultrathin bronchoscope, and guide sheath. We undertook this meta-analysis to determine the overall diagnostic yield of guided bronchoscopy using one or a combination of the modalities described here.
We performed a MEDLINE search using “bronchoscopy” and “solitary pulmonary nodule.” Studies evaluating the diagnostic yield of ENB, VB, R-EBUS, ultrathin bronchoscope, and/or guide sheath for peripheral nodules were included. The overall diagnostic yield and yield based on size were extracted. Adverse events, if reported, were recorded. Meta-analysis techniques incorporating inverse variance weighting and a random-effects meta-analysis approach were used.
A total of 3,052 lesions from 39 studies were included. The pooled diagnostic yield was 70%, which is higher than the yield for traditional transbronchial biopsy. The yield increased as the lesion size increased. The pneumothorax rate was 1.5%, which is significantly smaller than that reported for TTNA.
This meta-analysis shows that the diagnostic yield of guided bronchoscopic techniques is better than that of traditional transbronchial biopsy. Although the yield remains lower than that of TTNA, the procedural risk is lower. Guided bronchoscopy may be an alternative or be complementary to TTNA for tissue sampling of PN, but further study is needed to determine its role in the evaluation of peripheral pulmonary lesions.
随着国家肺癌筛查试验的开展,肺结节(PN)的检出率可能会增加。当需要组织诊断时,推荐使用经胸针吸活检(TTNA)。为了提高经支气管活检诊断 PN 的阳性率,已经开发了几种引导支气管镜技术:电磁导航支气管镜(ENB)、虚拟支气管镜(VB)、径向支气管内超声(R-EBUS)、超细支气管镜和引导鞘。我们进行了这项荟萃分析,以确定使用一种或多种这里描述的方法进行引导支气管镜检查的总体诊断阳性率。
我们使用“支气管镜”和“孤立性肺结节”进行了 MEDLINE 搜索。纳入了评估 ENB、VB、R-EBUS、超细支气管镜和/或引导鞘用于外周结节的诊断阳性率的研究。提取了总体诊断阳性率和基于大小的阳性率。如果有报道,记录了不良事件。采用包含倒数方差加权和随机效应荟萃分析方法的荟萃分析技术。
共纳入 39 项研究的 3052 个病灶。汇总的诊断阳性率为 70%,高于传统经支气管活检的阳性率。阳性率随着病灶大小的增加而增加。气胸发生率为 1.5%,明显小于 TTNA 报道的气胸发生率。
这项荟萃分析表明,引导支气管镜技术的诊断阳性率优于传统经支气管活检。尽管阳性率仍低于 TTNA,但手术风险较低。引导支气管镜可能是 TTNA 的替代方法或补充方法,用于 PN 的组织取样,但需要进一步研究来确定其在评估外周性肺部病变中的作用。